Literature DB >> 31559511

First evidence for a pharmacist-led anticoagulant clinic in a medicare part A long term care environment.

Jeffrey A Gray1, Ralph A Lugo2, Vivi N Patel2, Cindy J Pohland3, David W Stewart2.   

Abstract

Anticoagulation risks in older adult, long-term care patients are known to be high, especially in those with frequent transitions between care environments. Introduction of collaborative practice agreements (CPA) in specific settings is encouraged in the United States and has provided an additional option for the care of medically challenging patients. The aim of this study was to investigate the time in therapeutic range (TTR) in a Medicare Part A sponsored long-term care environment managed by pharmacists through a collaborative practice agreement in South-Central Appalachia. A retrospective review of all warfarin patient admissions from a large long-term care pharmacy's anticoagulant clinic was conducted for residents over an 18-month period. For all patients (n = 104), the overall TTR was 46.7% (INR 43% in range). Average management duration was 19.5 days per patient. Further studies are required to optimize CPA and transition strategies for complex, advanced age warfarin patients.

Entities:  

Keywords:  Anticoagulation; Collaborative practice; Long-term care; Medicare part A; Pharmacist; Warfarin

Mesh:

Substances:

Year:  2019        PMID: 31559511     DOI: 10.1007/s11239-019-01963-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  10 in total

Review 1.  Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review.

Authors:  Beenish S Manzoor; Wei-Han Cheng; James C Lee; Ellen M Uppuluri; Edith A Nutescu
Journal:  Ann Pharmacother       Date:  2017-07-22       Impact factor: 3.154

2.  Collaborative practice agreements a useful tool for researchers.

Authors:  Donald G Klepser
Journal:  J Am Pharm Assoc (2003)       Date:  2016 Nov - Dec

Review 3.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2019-01-28       Impact factor: 29.690

4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

5.  Potential benefits of warfarin monitoring by a clinical pharmacist in a long term care facility.

Authors:  Carol Motycka; Carl Kesgen; Steven M Smith; Edgar Alvarez; Kelly Jones
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

6.  Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report.

Authors:  Gregory Y H Lip; Amitava Banerjee; Giuseppe Boriani; Chern En Chiang; Ramiz Fargo; Ben Freedman; Deirdre A Lane; Christian T Ruff; Mintu Turakhia; David Werring; Sheena Patel; Lisa Moores
Journal:  Chest       Date:  2018-08-22       Impact factor: 9.410

Review 7.  Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis.

Authors:  S Zhou; X Y Sheng; Q Xiang; Z N Wang; Y Zhou; Y M Cui
Journal:  J Clin Pharm Ther       Date:  2016-09-28       Impact factor: 2.512

8.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

9.  Rates of hemorrhage during warfarin therapy for atrial fibrillation.

Authors:  Tara Gomes; Muhammad M Mamdani; Anne M Holbrook; J Michael Paterson; Chelsea Hellings; David N Juurlink
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

Review 10.  Clinical impact of a pharmacist-led inpatient anticoagulation service: a review of the literature.

Authors:  Tiffany Lee; Erin Davis; Jason Kielly
Journal:  Integr Pharm Res Pract       Date:  2016-05-26
  10 in total
  1 in total

1.  Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.

Authors:  Maria R Bernstein; Libiny John; Susan Sciortino; Elise Arambages; Danielle Auletta; Alex C Spyropoulos
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.